High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment

BACKGROUND: This report addresses how patients with hereditary hemorrhagic telangiectasia (HHT) and high output cardiac failure (HOCF) due to hepatic vascular malformations, should be evaluated and could be treated. HHT is a genetic disorder, leading to vascular abnormalities with potentially seriou...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Lilian B., Kjeldsen, Anette D., Poulsen, Mikael K., Kjeldsen, Jens, Fialla, Annette D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691053/
https://www.ncbi.nlm.nih.gov/pubmed/33243256
http://dx.doi.org/10.1186/s13023-020-01583-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691053/
https://www.ncbi.nlm.nih.gov/pubmed/33243256
http://dx.doi.org/10.1186/s13023-020-01583-6

Ejemplares similares